Biotech Start-up BugBiome Secures Investment for Pioneering Research in Sustainable Pest Protection
Pictured: The BugBiome Team (left to right): Chris Mosedale, Co-founder & CCO, Alicia Showering, Co-founder & CEO, Bob Jones, Microbiologis BugBiome raises £310k in pre-seed investment from Cambridge Angels and Discovery Park Ventures Investment...
JP Morgan Healthcare Conference: highlights and industry outlook
Mayer Schreiber, CEO of Discovery Park, and Chris Broom, Head of Business Development at Discovery Park, recently attended the JP Morgan Healthcare Conference in San Francisco to build global connections and raise awareness of the opportunities in the UK for the...
Discovery Park Ventures Invests £100K in New Tenant Vox Imaging Technology to Advance Ophthalmic Imaging for Preclinical Research
Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and...
BugBiome wins Discovery Spark life science programme
BugBiome was announced as the winner of the Discovery Spark life science business support programme at the GIANT Health Healthcare Investment Show on 5th December. BugBiome will be awarded a business support package worth over £100,000, including one year of free lab...
Discovery Park Ventures expands fund to £3m to invest in more innovative science and technology start-ups
Discovery Park Ventures (DPV) announces the expansion of its early-stage life science fund from £1m to £3m, in order to capitalise on exciting investment opportunities and support its existing portfolio. The fund’s investors have committed an additional £2m, which...
